Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELIPS-Trial
2025-523151-66-00Phase 4Authorised
- Sponsor
- Johannes Kepler University Linz
- Start
- Jan 2026
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies
- Countries
- 1
01
Overview
Phase 4 trial of LyoPlas in hemorrhagic shock, sponsored by Johannes Kepler University Linz. Planned start Jan 2026; status: authorised.
02
Drugs
LyoPlas
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on 2025-523151-66-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523151-66-00.